Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
10/04/2012 | WO2012078752A3 Serine protease inhibitor kazal antibodies |
10/04/2012 | WO2012078327A9 Fluid system health monitor |
10/04/2012 | WO2012077983A3 Bladder cancer diagnosis composition containing ape1/ref-1 and bladder cancer diagnosis kit using same |
10/04/2012 | WO2012077933A3 Urine collecting device for a toilet seat-mounted urinalysis system |
10/04/2012 | WO2012076729A9 Method for staging cancer progression by afm |
10/04/2012 | WO2012074308A3 Sampler |
10/04/2012 | WO2012065075A3 Electrokinetic devices and methods for high conductance and high voltage dielectrophoresis (dep) |
10/04/2012 | WO2012058201A3 Method for determining activators of excitatory synapse formation |
10/04/2012 | WO2012054523A3 Chemosensory receptor ligand-based therapies |
10/04/2012 | WO2012050828A3 Serum markets for identification of cutaneous systemic sclerosis subjects |
10/04/2012 | WO2012044987A3 Genetic modifiers of cystic fibrosis |
10/04/2012 | US20120255040 Cell Model and Methods Using the Same |
10/04/2012 | US20120253960 Methods, software arrangements, storage media, and systems for providing a shrinkage-based similarity metric |
10/04/2012 | US20120253020 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways |
10/04/2012 | US20120253018 Bovine Adeno-Associated Viral (BAAV) Vector and Uses Thereof |
10/04/2012 | US20120252904 Mitf as a marker for predisposition to cancer |
10/04/2012 | US20120252896 Methods and compositions for modulation of t-cells via the kynurenine pathway |
10/04/2012 | US20120252894 Compounds for alleviating pain and stress in fetus and newborn |
10/04/2012 | US20120252878 Use of cathepsin h |
10/04/2012 | US20120252870 Indian Hedgehog (Ihh) as a Marker to Predict Osteoarthritis (OA) and Methods for the Prevention and Treatment of OA |
10/04/2012 | US20120252868 Novel means and methods for the treatment of hearing loss and phantom hearing |
10/04/2012 | US20120252867 Method of therapy and diagnosis of atherosclerosis |
10/04/2012 | US20120252856 Pi3k/akt pathway subgroups in cancer: methods of using biomarkers for diagnosis and therapy |
10/04/2012 | US20120252796 Compounds for the treatment of dyslipidemia and related diseases |
10/04/2012 | US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase |
10/04/2012 | US20120252787 Administration of an anti-obesity compound to individuals with renal impairment |
10/04/2012 | US20120252752 Compositions, methods and kits for repressing virulence in gram positive bacteria |
10/04/2012 | US20120252749 Methods of Treating Cancer with Glut Inhibitors |
10/04/2012 | US20120252748 Methods and compositions for determining the responsiveness of cancer therapeutics |
10/04/2012 | US20120252737 Methods for Diagnosing and Treating Cancer |
10/04/2012 | US20120252726 Novel neurotrophic factors |
10/04/2012 | US20120252717 Conjugates of biologically active proteins having a modified in vivo half-life |
10/04/2012 | US20120252703 Method and system for capture and use of intact vesicles on electrodeposited hydrophobically modified biopolymer films |
10/04/2012 | US20120252695 Predictive Value of IL28B Gene Polymorphism Combined with Pretreatment Serum IP-10 Quantification for Response to Peginterferon and Ribavirin Is Enhanced in Comparison with any of these Biomarkers alone |
10/04/2012 | US20120252691 Modified nucleotides methods and kits |
10/04/2012 | US20120252688 Novel biomarkers of disease histopathology |
10/04/2012 | US20120252138 Methods and Related Devices for Continuous Sensing Utilizing Magnetic Beads |
10/04/2012 | US20120252133 Test meter with a strip port connector configured for fluid entrapment |
10/04/2012 | US20120252099 Immunogenic minicells and methods of use |
10/04/2012 | US20120252053 Reagents and methods and systems using them |
10/04/2012 | US20120252048 Compositions comprising a dehalogenase substrate and a contrast agent and methods of use |
10/04/2012 | US20120252043 Blood coagulation time determination method and apparatus |
10/04/2012 | US20120252042 Artificial Feces |
10/04/2012 | US20120252041 Method of prognosis |
10/04/2012 | US20120252040 Kit for diagnosing prostate cancer and diagnosis method |
10/04/2012 | US20120252039 Plasma kallikrein fragments as diagnostic biomarkers for lung cancers |
10/04/2012 | US20120252038 Steroid receptor assays |
10/04/2012 | US20120252037 Stimulatory auto-antibodies to the pdgf receptor as pathology marker and therapeutic target |
10/04/2012 | US20120252036 Diagnostic tests for abnormal ovarian conditions |
10/04/2012 | US20120252034 Quality assays for antigen presenting cells |
10/04/2012 | US20120252033 Substance determining apparatus |
10/04/2012 | US20120252032 Immunoassay Device with Improved Sample Closure |
10/04/2012 | US20120252031 Compositions and methods for regulating sas1r |
10/04/2012 | US20120252022 Methods and compositions for the diagnosis and treatment of thyroid cancer |
10/04/2012 | US20120252018 Method of detecting an analyte in a sample using semiconductor nanocrystals as a detectable label |
10/04/2012 | US20120252009 Methods and Compositions for Enriching Either Target Polynucleotides or Non-Target Polynucleotides from a Mixture of Target and Non-Target Polynucleotides |
10/04/2012 | US20120252006 Methods and Systems for Multiple Control Validation |
10/04/2012 | US20120251697 Machine for making and dispensing semiliquid and/or semisolid products |
10/04/2012 | US20120251578 Diagnostic, Therapeutic And A Vaccine Against Treponemes |
10/04/2012 | US20120251565 Compositions and methods for preventing or treating burkholderia infection |
10/04/2012 | US20120251564 Reovirus compositions and methods of use |
10/04/2012 | US20120251557 GalNAc-SPECIFIC BINDING MOLECULES AND USES THEREOF |
10/04/2012 | US20120251555 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
10/04/2012 | US20120251553 Biomarkers for schizophrenia or other psychotic disorders |
10/04/2012 | US20120251552 Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation |
10/04/2012 | US20120251542 Anti-toxin vaccine compositions and methods of use thereof |
10/04/2012 | US20120251540 Stabilized single domain antibodies |
10/04/2012 | US20120251532 Anti-alpha v beta 6 antibodies |
10/04/2012 | US20120251527 Podocyte specific assays and uses thereof |
10/04/2012 | US20120251524 Use of cytokine levels in intravenous immunoglobulin treatment of alzheimer's disease |
10/04/2012 | US20120251523 Methods of Modulating TGFbeta Signaling |
10/04/2012 | US20120251505 HUMAN LYMPHOID TISSUE INDUCER (LTi) CELL COMPOSITIONS AND METHODS OF USE |
10/04/2012 | US20120251457 Methods and compositions for modulating adipocyte function |
10/04/2012 | US20120251455 Hair Growth-Inhibiting Agent |
10/04/2012 | US20120251440 Methods of myocardial perfusion imaging |
10/04/2012 | US20120251417 Method for Recovering Metal, and Reagent and Kit for Recovery of Metal for Use in the Same |
10/04/2012 | US20120251390 Method for Recovering Metal and Kit for Recovery of Metal for Use in the Same |
10/04/2012 | US20120247977 Methods and apparatus for measuring analytes using large scale fet arrays |
10/04/2012 | US20120247976 Non-Invasive Glucose Sensor |
10/04/2012 | US20120247964 Microfluidic control device for measuring glycoslyated hemoglobin, method for manufacturing the same and method for operating the same |
10/04/2012 | US20120247610 Method for automatically inspecting a beverage processing plant |
10/04/2012 | US20120247191 Combined hydrogen and pressure sensor assembly |
10/04/2012 | US20120247187 Sensor mounting into the temperature well of a transformer |
10/04/2012 | US20120247182 Mobile scent tester |
10/04/2012 | DE202012008547U1 Diagnostisches Laborgerät zur Verarbeitung von Proben mit sog. Blot-Methoden Diagnostic Laboratory apparatus for processing samples with known. Blot methods |
10/04/2012 | DE112009004291T5 Automatischer Analysator The automated analyzer |
10/04/2012 | DE102011015500A1 Device for determining quality of liquid fuel in fuel tank of motor car, has temperature sensor designed as floating sensor and positioned in region of liquid surface of liquid fuel to measure temperature of liquid fuel on liquid surface |
10/04/2012 | DE102011015476A1 Device for static, dynamic or intermittent conducted aging test of rubber or vulcanized or thermoplastic elastomer in test chamber, has test chamber that is provided with supply line and outlet line |
10/04/2012 | DE102011015321A1 Method for separating leucocyte from blood, involves forming openings through which to-be-separated particles are deflected in separation channel |
10/04/2012 | DE102011006349A1 Vorrichtung und Verfahren zur Detektion, Vermessung und/oder Beeinflussung der Gerinnung von Blutsystemen Apparatus and method for the detection, measurement and / or alterations of the coagulation of blood systems |
10/04/2012 | DE102011006311A1 Arrangement for monitoring liquid medium in channel system for e.g. fermentation plant, has magnetic systems arranged such that field is extended to interact with element, where element is connected with probe so to produce force on probe |
10/04/2012 | DE102008048605B4 Verfahren zur Markierung und/oder Identifizierung von Biomolekülen A method of marking and / or identification of biomolecules |
10/04/2012 | CA2831867A1 Therapeutic agent for cancer, and method for determining prognosis of cancer |
10/04/2012 | CA2831863A1 Use of cytokine levels in intravenous immunoglobulin treatment of alzheimer's disease |
10/04/2012 | CA2831857A1 Dialysis like therapeutic (dlt) device |
10/04/2012 | CA2831743A1 Method for estimating content of fine particles in slurry and process for producing hydrocarbon oil |
10/04/2012 | CA2831725A1 Method for determining exposure to mycobacteria |
10/04/2012 | CA2831567A1 Steroid receptor assays for detecting tumor cells |
10/04/2012 | CA2831544A1 Latex particle for measurement reagent, coated latex particle, and measurement reagent for immunoturbidimetric method |
10/04/2012 | CA2831454A1 Modulators of plexin b2 activity |